Assignee
ABGENIX INC
US·31 granted patents·10 pending applications·18,246 citations·filing 1992–2007
Top patents by PatentIndex Score
41 records- 0199US6458592B1Production of antibodies using cre-mediated site-specific recombinationABGENIX INC·Filed 2000·Granted Oct 1, 2002·126 cites·22 claims
- 0299US6130364AProduction of antibodies using Cre-mediated site-specific recombinationABGENIX INC·Filed 1995·Granted Oct 10, 2000·521 cites·27 claims
- 0399US6091001AProduction of antibodies using Cre-mediated site-specific recombinationABGENIX INC·Filed 1995·Granted Jul 18, 2000·502 cites·4 claims
- 0499US5939598AMethod of making transgenic mice lacking endogenous heavy chainsABGENIX INC·Filed 1992·Granted Aug 17, 1999·2.6k cites·13 claims
- 0598US7338660B2Methods of treating cancer and enhancing immune responses with antibodies that bind CD40ABGENIX INC·Filed 2005·Granted Mar 4, 2008·144 cites·73 claims
- 0698US6682736B1Human monoclonal antibodies to CTLA-4ABGENIX INC·Filed 1999·Granted Jan 27, 2004·776 cites·104 claims
- 0798US6673986B1Generation of xenogeneic antibodiesABGENIX INC·Filed 1993·Granted Jan 6, 2004·478 cites·3 claims
- 0898US6235883B1Human monoclonal antibodies to epidermal growth factor receptorABGENIX INC·Filed 1997·Granted May 22, 2001·831 cites·16 claims
- 0998US6162963AGeneration of Xenogenetic antibodiesABGENIX INC·Filed 1995·Granted Dec 19, 2000·1.3k cites·21 claims
- 1098US6150584AHuman antibodies derived from immunized xenomiceABGENIX INC·Filed 1996·Granted Nov 21, 2000·3.1k cites·12 claims
- 1198US6075181AHuman antibodies derived from immunized xenomiceABGENIX INC·Filed 1995·Granted Jun 13, 2000·3.1k cites·3 claims
- 1298US5916771AProduction of a multimeric protein by cell fusion methodABGENIX INC·Filed 1996·Granted Jun 29, 1999·1k cites·11 claims
- 1397US7563442B2Antibodies to CD40 and methods of treating cancer and enhancing immune responsesABGENIX INC·Filed 2005·Granted Jul 21, 2009·62 cites·133 claims
- 1497US7064244B2Transgenic mammals having human Ig loci including plural VH and VK regions and antibodies produced therefromABGENIX INC·Filed 2002·Granted Jun 20, 2006·197 cites·6 claims
- 1597US7049426B2Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regionsABGENIX INC·Filed 2001·Granted May 23, 2006·162 cites·16 claims
- 1697US6833268B1Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regionsABGENIX INC·Filed 1999·Granted Dec 21, 2004·211 cites·4 claims
- 1797US6657103B1Human antibodies derived from immunized xenomiceABGENIX INC·Filed 1997·Granted Dec 2, 2003·260 cites·4 claims
- 1897US6114598AGeneration of xenogeneic antibodiesABGENIX INC·Filed 1995·Granted Sep 5, 2000·1.5k cites·5 claims
- 1997US5985615ADirected switch-mediated DNA recombinationABGENIX INC·Filed 1997·Granted Nov 16, 1999·346 cites·31 claims
- 2096US7202343B2Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereofABGENIX INC·Filed 2003·Granted Apr 10, 2007·78 cites·39 claims
- 2195US7067131B2Methods for using anti-MUC18 antibodiesABGENIX INC·Filed 2002·Granted Jun 27, 2006·61 cites·21 claims
- 2295US6924360B2Antibodies against the MUC18 antigenABGENIX INC·Filed 2002·Granted Aug 2, 2005·79 cites·57 claims
- 2395US6420140B1Production of multimeric protein by cell fusion methodABGENIX INC·Filed 2001·Granted Jul 16, 2002·122 cites·27 claims
- 2495US6207418B1Production of a multimeric protein by cell fusion methodABGENIX INC·Filed 1999·Granted Mar 27, 2001·86 cites·11 claims
- 2591US7141653B2Human monoclonal antibodies to interleukin-5ABGENIX INC·Filed 2003·Granted Nov 28, 2006·59 cites·9 claims
- 2691US7090844B2Use of antibodies against the MUC18 antigenABGENIX INC·Filed 2003·Granted Aug 15, 2006·48 cites·27 claims
- 2791US5998209AGeneration of large genomic DNA deletionsABGENIX INC·Filed 1997·Granted Dec 7, 1999·344 cites·18 claims
- 2888US7078492B2Human antipneumococcal antibodies from non-human animalsABGENIX INC·Filed 2003·Granted Jul 18, 2006·65 cites·11 claims
- 2985US6677138B2Production of a multimeric protein by cell fusion methodABGENIX INC·Filed 2001·Granted Jan 13, 2004·8 cites·8 claims
- 3067US2005100546A1Human monoclonal antibodies to epidermal growth factor receptorABGENIX INC·Filed 2004·Application pending·0 cites
- 3162US2010010202A1Human antibodies derived from immunized xenomiceABGENIX INC·Filed 2007·Application pending·0 cites
- 3259US2009149637A1Human antibodies derived from immunized xenomiceABGENIX INC·Filed 2007·Application pending·0 cites
- 3356US2003092125A1Epitope-driven human antibody production and gene expression profilingABGENIX INC·Filed 2002·Application pending·0 cites
- 3455US2005287630A1Human antibodies derived from immunized xenomiceABGENIX INC·Filed 2004·Application pending·0 cites
- 3555US2005241006A1Human antibodies derived from immunized xenomiceABGENIX INC·Filed 2004·Application pending·0 cites
- 3654US2005076395A1Generation of xenogeneic antibodiesABGENIX INC·Filed 2004·Application pending·0 cites
- 3752US2004093622A1Generation of xenogeneic antibodiesABGENIX INC·Filed 2003·Application pending·0 cites
- 3851US2007048305A1CD147 binding molecules as therapeuticsABGENIX INC·Filed 2006·Application pending·0 cites
- 3950US2004010810A1Generation of xenogeneic antibodiesABGENIX INC·Filed 2003·Application pending·0 cites
- 4041US6395515B1Directed switch-mediated DNA recombinationABGENIX INC·Filed 1999·Granted May 28, 2002·2 cites·3 claims
- 4138US6884622B1Method for preparing a mammalian cell deficient in HPRTABGENIX INC·Filed 2000·Granted Apr 26, 2005·0 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when ABGENIX INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →